April 29 – Breakingviews columnists discuss the U.S. drug giant’s hankering for AstraZeneca and whether more so-called inversion deals will …read more
Via:: Reuters Video: Top News
April 29 – Breakingviews columnists discuss the U.S. drug giant’s hankering for AstraZeneca and whether more so-called inversion deals will …read more
Via:: Reuters Video: Top News